1. Home
  2. CHD vs INSM Comparison

CHD vs INSM Comparison

Compare CHD & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHD
  • INSM
  • Stock Information
  • Founded
  • CHD 1846
  • INSM 1988
  • Country
  • CHD United States
  • INSM United States
  • Employees
  • CHD N/A
  • INSM 1271
  • Industry
  • CHD Package Goods/Cosmetics
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHD Consumer Discretionary
  • INSM Health Care
  • Exchange
  • CHD Nasdaq
  • INSM Nasdaq
  • Market Cap
  • CHD 24.1B
  • INSM 23.5B
  • IPO Year
  • CHD N/A
  • INSM 2000
  • Fundamental
  • Price
  • CHD $91.25
  • INSM $113.59
  • Analyst Decision
  • CHD Buy
  • INSM Strong Buy
  • Analyst Count
  • CHD 14
  • INSM 17
  • Target Price
  • CHD $108.14
  • INSM $111.73
  • AVG Volume (30 Days)
  • CHD 2.3M
  • INSM 2.6M
  • Earning Date
  • CHD 08-01-2025
  • INSM 08-07-2025
  • Dividend Yield
  • CHD 1.30%
  • INSM N/A
  • EPS Growth
  • CHD N/A
  • INSM N/A
  • EPS
  • CHD 2.12
  • INSM N/A
  • Revenue
  • CHD $6,066,000,000.00
  • INSM $398,105,000.00
  • Revenue This Year
  • CHD $1.21
  • INSM $28.23
  • Revenue Next Year
  • CHD $3.77
  • INSM $119.99
  • P/E Ratio
  • CHD $42.84
  • INSM N/A
  • Revenue Growth
  • CHD 1.13
  • INSM 21.15
  • 52 Week Low
  • CHD $90.51
  • INSM $60.40
  • 52 Week High
  • CHD $116.46
  • INSM $113.10
  • Technical
  • Relative Strength Index (RSI)
  • CHD 34.84
  • INSM 71.99
  • Support Level
  • CHD $90.51
  • INSM $106.54
  • Resistance Level
  • CHD $93.29
  • INSM $113.10
  • Average True Range (ATR)
  • CHD 1.75
  • INSM 3.19
  • MACD
  • CHD -0.47
  • INSM 0.10
  • Stochastic Oscillator
  • CHD 9.51
  • INSM 95.32

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Most recently, the firm announced the addition of Touchland, and its hand santizer business, to its fold. Even as it works to grow the reach of its products, Church & Dwight still derives around 80% of its sales from its home market in the US.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: